Skip to main content
Log in

Long-term follow-up of re-sting reactions in children with moderate to severe venom hypersensitivity

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Few data exists about re-sting reactions and their prognosis in children with moderate to severe venom hypersensitivity. The reasons behind not consenting to or prematurely ending venom immunotherapy (VIT) and the preparedness of children who refused or quit VIT for future moderate–severe systemic reaction (SR) to re-stings have not been studied. Data on children with moderate to severe SR after Hymenoptera stings was collected for a 17-year period using our database. A standardized questionnaire was administered to patients who accepted to be interviewed at the clinic. These patients were evaluated in terms of their preparedness for future moderate–severe SR to re-stings. A total of 55 children, 75 % of whom commenced on VIT, were included in the analysis. Different reasons exist for not consenting to VIT; the most common of which is living at a distance from the allergy center. There were no differences in terms of the number of re-stung patients (27.7 and 27.2 %, respectively) and moderate–severe SR (60 and 16.6 %, respectively) between children who prematurely ended or who did not consent to VIT and children who completed VIT. Sixty-four percent of the children who refused or discontinued VIT were not prepared for future moderate–severe SR to re-stings.

Conclusion: Long-term prognosis for re-sting reactions is good in children with moderate to severe SR to venoms. Some of the reasons behind refusing or discontinuing VIT may be related to quality of life issues. Preparedness of children who refused or discontinue VIT in emergencies is very low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

BSACI:

British Society for Allergy and Clinical Immunology

LLR:

Large local reaction

SIgE:

Specific IgE

SRs:

Systemic reactions

QoL:

Quality of life

VIT:

Venom immunotherapy

References

  1. Boyle RJ, Dickson R, Hockenhull J, Cherry MG, Elremeli M (2013) Immunotherapy for Hymenoptera venom allergy: too expensive for European health care? Allergy 68(10):1341–1342

    Article  CAS  PubMed  Google Scholar 

  2. Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN (2012) Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev 10, CD008838

    PubMed  Google Scholar 

  3. Golden DB, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM (2004) Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 351(7):668–674

    Article  CAS  PubMed  Google Scholar 

  4. Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, Tracy JM, Bernstein D, Blessing-Moore J, Cox L, Khan DA, Lang DM, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles SA, Wallace D, Joint Task Force On Practice Parameters; American Academy Of Allergy, Asthma & Immunology (Aaaai); American College Of Allergy, Asthma & Immunology (Acaai); Joint Council Of Allergy, Asthma And Immunology (2011) Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 127(4):852–4

    Article  Google Scholar 

  5. Gruchalla RS (2004) Immunotherapy in allergy to insect stings in children. N Engl J Med 351:707–709

    Article  CAS  PubMed  Google Scholar 

  6. Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, Nasser SM (2011) Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy 41(9):1201–1220

    Article  CAS  PubMed  Google Scholar 

  7. Ruëff F, Biló MB, Cichocka-Jarosz E, Müller U, Oude Elberink H, Sturm G (2013) Immunotherapy for hymenoptera venom allergy: too expensive for European health care? Allergy 68(4):407–8

    Article  PubMed  Google Scholar 

  8. Stritzke AI, Eng PA (2013) Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom. Clin Exp Allergy 43(8):950–55

    Article  CAS  PubMed  Google Scholar 

  9. Von Moos S, Graf N, Johansen P, Müllner G, Kündig TM, Senti G (2013) Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy. Int Arch Allergy Immunol 160(1):86–92

    Article  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hacer Ilbilge Ertoy Karagol.

Additional information

Communicated by David Nadal

Revisions received: 29 October 2014 / 06 December 2014

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ertoy Karagol, H.I., Bakirtas, A., Yilmaz, O. et al. Long-term follow-up of re-sting reactions in children with moderate to severe venom hypersensitivity. Eur J Pediatr 174, 891–896 (2015). https://doi.org/10.1007/s00431-014-2478-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-014-2478-0

Keywords

Navigation